agros alfa c emulsionskoncentrat
agros - alpha-cypermethrin - emulsionskoncentrat - 50 g/l alpha-cypermethrin
fastac emulsionskoncentrat
cyanamid danmark a/s - alpha-cypermethrin - emulsionskoncentrat - 100 g/l alpha-cypermethrin
fastac emulsionskoncentrat
3a kemi a/s - alpha-cypermethrin - emulsionskoncentrat - 50 g/l alpha-cypermethrin
fastac t granulat
basf a/s - alpha-cypermethrin - granulat - 150 kg alpha-cypermethrin
alkeran 2 mg filmovertrukne tabletter
abacus medicine a/s - melphalan - filmovertrukne tabletter - 2 mg
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multipelt myelom - antineoplastiske midler - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - svin - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
human igg1 monoclonal antibody specific for human interleukin-1 alpha xbiotech
xbiotech germany gmbh - humant igg1 monoklonalt antistof specifikt for human interleukin-1 alfa - kolorektale neoplasmer - antineoplastiske midler - behandling af metastatisk kolorektal cancer.